105
105
Description
Stronger economic fundamentals and vaccination progress mean the 2022 outlook for Asian equities, and more broadly global emerging market equities, is rosier now than it was at this time a year ago, argues Zhikai Chen, head of Asian equities.
Hosted by Ausha. See ausha.co/privacy-policy for more information.
Description
Stronger economic fundamentals and vaccination progress mean the 2022 outlook for Asian equities, and more broadly global emerging market equities, is rosier now than it was at this time a year ago, argues Zhikai Chen, head of Asian equities.
Hosted by Ausha. See ausha.co/privacy-policy for more information.
Share
Embed
You may also like
Talking Heads – The weighty impact of anti-obesity drugs, also for investors
Talking Heads – Getting Asia on board on climate and nature goals
Talking Heads – Exchange-traded funds: adding ESG into the mix
Talking Heads – Investing in global equities with a net zero tilt
Talking Heads – Money market funds can still work when rates rise
Description
Stronger economic fundamentals and vaccination progress mean the 2022 outlook for Asian equities, and more broadly global emerging market equities, is rosier now than it was at this time a year ago, argues Zhikai Chen, head of Asian equities.
Hosted by Ausha. See ausha.co/privacy-policy for more information.
Description
Stronger economic fundamentals and vaccination progress mean the 2022 outlook for Asian equities, and more broadly global emerging market equities, is rosier now than it was at this time a year ago, argues Zhikai Chen, head of Asian equities.
Hosted by Ausha. See ausha.co/privacy-policy for more information.
Share
Embed
You may also like
Talking Heads – The weighty impact of anti-obesity drugs, also for investors
Talking Heads – Getting Asia on board on climate and nature goals
Talking Heads – Exchange-traded funds: adding ESG into the mix
Talking Heads – Investing in global equities with a net zero tilt
Talking Heads – Money market funds can still work when rates rise